Recently, FGFR3-transforming acidic coiled-coil 3 (TACC3) fusions have been identified in glioblastoma[7], head and neck carcinoma[8], and lung cancer[9], as well as urothelial cancer (UC)[10]. The gene discussed is TACC3; the disease is glioblastoma.